Zhuyin Li
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Cardiac Valve Diseases and Treatments, Cell Image Analysis Techniques, Computational Drug Discovery Methods, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors(2016)598 cited
- → Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction(2020)390 cited
- Assay Guidance Manual [Internet](2004)
- → Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction(2020)204 cited
- → Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy(2015)177 cited
- → Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models(2016)148 cited
- Assay Guidance Manual(2004)
- → Multiplexed ion beam imaging (MIBI) for characterization of the tumor microenvironment across tumor types(2020)107 cited
- → Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1(2014)92 cited
- → Symptom Onset in Aortic Stenosis(2017)90 cited